Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$937b Graphic](https://lunarcrush.com/gi/w:26/t:$937b.png) $937b

Crypto market sees mixed signals as some coins show gains while others struggle. Investors are cautiously watching for further market direction.

### About $937b
A cryptocurrency.  

### Insights [#](/topic/$937b/insights)
- $937b engagements is up XXXXXXXX% from the previous month.

### Engagements: XX [#](/topic/$937b/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$937b/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$937b/time-series/interactions.tsv)  
**Current Value**: XX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXX +714%  
**1 Month**: XXXXXX +1,539%  
**1-Year High**: XXXXXXX on 2025-07-23  
**1-Year Low**: X on 2025-07-01  

| Social Network | X  |
| -------------- | -  |
| Engagements    | XX |
  

  
  
### Mentions: X [#](/topic/$937b/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$937b/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$937b/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Month**: XX +325%  
**1-Year High**: XX on 2025-07-24  
**1-Year Low**: X on 2025-05-05  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$937b/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$937b/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$937b/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $937b in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: X  
**1 Month**: XX +250%  
**1-Year High**: XX on 2025-07-24  
**1-Year Low**: X on 2025-05-05  

The most influential creators that mention $937b in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) | X    | XXXXX     | X     | X           |

[View More](/list/creators/$937b/100)
  
  
### Sentiment: % [#](/topic/$937b/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$937b/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$937b/time-series/sentiment.tsv)  
**Current Value**: %  
**Daily Average**: XX%  
**1-Year High**: XXX% on 2025-06-24  
**1-Year Low**: X% on 2025-07-23  

**Top assets mentioned**
In the posts about $937b in the last XX hours

[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Johnson & Johnson (JNJ)](/topic/$jnj)
[Toyota Motor Corporation (TM)](/topic/$tm)
[Sumitomo Mitsui Financial Group, Inc (SMFG)](/topic/$smfg)

**Top topics mentioned**
In the posts about $937b in the last XX hours

[johnson johnson](/topic/johnson-johnson), [stocks healthcare](/topic/stocks-healthcare), [$jnj](/topic/$jnj), [$240b](/topic/$240b), [$515b](/topic/$515b), [$2399b](/topic/$2399b), [$24b](/topic/$24b), [outlook](/topic/outlook), [$2376b](/topic/$2376b), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [$tm](/topic/$tm), [$2512b](/topic/$2512b), [$smfg](/topic/$smfg), [$8309t](/topic/$8309t), [has been](/topic/has-been), [liquidated](/topic/liquidated), [#crypto](/topic/#crypto), [supported](/topic/supported), [wall street](/topic/wall-street), [$jnjs](/topic/$jnjs), [$30b](/topic/$30b), [$29b](/topic/$29b), [$20b](/topic/$20b), [$8b](/topic/$8b)

### Top Social Posts [#](/topic/$937b/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Johnson & Johnson Q3 2025 delivered steady growth alongside active portfolio moves. - Sales came in at $23.99B up XXX% YoY reflecting solid demand across key therapies and devices. - Adjusted EPS was $XXXX supported by operating discipline despite ongoing R&D and launch investments. - For 2025 management reaffirmed guidance with a sales midpoint of $93.7B and EPS outlook maintained signaling confidence in the trajectory. - By segment Innovative Medicine grew XXX% YoY on continued uptake of priority brands while MedTech also rose XXX% YoY aided by procedure volumes and new products. - On the"  
[X Link](https://x.com/provue_ai/status/1978760600902885879) [@provue_ai](/creator/x/provue_ai) 2025-10-16T09:51Z XXX followers, XX engagements


"🦉 $JNJ Johnson & Johnson Q3 2025 sales rose XXX% to $24B with EPS doubling to $XXXX (adj. $2.80). Oncology up XX% driven by DARZALEX & CARVYKTI. FY sales outlook raised to $93.7B. $JNJ #stocks #form8K #news"  
[X Link](https://x.com/AponiaAnalytics/status/1978117373887381517) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-10-14T15:15Z 5209 followers, XXX engagements


"🦉 Johnson & Johnson $JNJ Reports Q3 2025 Results; Raises 2025 Sales Outlook Johnson & Johnson Q3 sales rose XXX% to $24B EPS $XXXX adj. Raises 2025 sales outlook to $93.7B driven by new cancer and heart drug gains. $JNJ #stocks #reports"  
[X Link](https://x.com/AponiaAnalytics/status/1978106058842276067) [@AponiaAnalytics](/creator/x/AponiaAnalytics) 2025-10-14T14:30Z 5200 followers, XX engagements


"$JNJ J&J is -XXX% this morning. 🔹 EPS: $XXXX vs. $XXXX est. ✅ 🔹 Revenue: $23.76B vs. $23.99B est. ✅ Key takeaways: 🔸 Innovative med rev: +7% YoY 🔸 MedTech rev: +7% YoY 🔸 Plans to split Orthopaedics into standalone business 🔸 FY rev outlook: $93.7B ($93.4B prior)"  
[X Link](https://x.com/marketsday/status/1978074931398123702) [@marketsday](/creator/x/marketsday) 2025-10-14T12:26Z 19.7K followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$937b Graphic $937b

Crypto market sees mixed signals as some coins show gains while others struggle. Investors are cautiously watching for further market direction.

About $937b

A cryptocurrency.

Insights #

  • $937b engagements is up XXXXXXXX% from the previous month.

Engagements: XX #


Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
1 Week: XXXXXX +714%
1 Month: XXXXXX +1,539%
1-Year High: XXXXXXX on 2025-07-23
1-Year Low: X on 2025-07-01

Social Network X
Engagements XX

Mentions: X #


Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: XX +325%
1-Year High: XX on 2025-07-24
1-Year Low: X on 2025-05-05

Social Network X
Mentions XX

Creators: X #


Creators Line Chart
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $937b in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: X
1 Month: XX +250%
1-Year High: XX on 2025-07-24
1-Year Low: X on 2025-05-05

The most influential creators that mention $937b in the last XX hours

Creator Rank Followers Posts Engagements
@AponiaAnalytics X XXXXX X X

View More

Sentiment: % #


Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1-Year High: XXX% on 2025-06-24
1-Year Low: X% on 2025-07-23

Top assets mentioned In the posts about $937b in the last XX hours

Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Toyota Motor Corporation (TM) Sumitomo Mitsui Financial Group, Inc (SMFG)

Top topics mentioned In the posts about $937b in the last XX hours

johnson johnson, stocks healthcare, $jnj, $240b, $515b, $2399b, $24b, outlook, $2376b, stocks consumer cyclical, $tm, $2512b, $smfg, $8309t, has been, liquidated, #crypto, supported, wall street, $jnjs, $30b, $29b, $20b, $8b

Top Social Posts #


Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"Johnson & Johnson Q3 2025 delivered steady growth alongside active portfolio moves. - Sales came in at $23.99B up XXX% YoY reflecting solid demand across key therapies and devices. - Adjusted EPS was $XXXX supported by operating discipline despite ongoing R&D and launch investments. - For 2025 management reaffirmed guidance with a sales midpoint of $93.7B and EPS outlook maintained signaling confidence in the trajectory. - By segment Innovative Medicine grew XXX% YoY on continued uptake of priority brands while MedTech also rose XXX% YoY aided by procedure volumes and new products. - On the"
X Link @provue_ai 2025-10-16T09:51Z XXX followers, XX engagements

"🦉 $JNJ Johnson & Johnson Q3 2025 sales rose XXX% to $24B with EPS doubling to $XXXX (adj. $2.80). Oncology up XX% driven by DARZALEX & CARVYKTI. FY sales outlook raised to $93.7B. $JNJ #stocks #form8K #news"
X Link @AponiaAnalytics 2025-10-14T15:15Z 5209 followers, XXX engagements

"🦉 Johnson & Johnson $JNJ Reports Q3 2025 Results; Raises 2025 Sales Outlook Johnson & Johnson Q3 sales rose XXX% to $24B EPS $XXXX adj. Raises 2025 sales outlook to $93.7B driven by new cancer and heart drug gains. $JNJ #stocks #reports"
X Link @AponiaAnalytics 2025-10-14T14:30Z 5200 followers, XX engagements

"$JNJ J&J is -XXX% this morning. 🔹 EPS: $XXXX vs. $XXXX est. ✅ 🔹 Revenue: $23.76B vs. $23.99B est. ✅ Key takeaways: 🔸 Innovative med rev: +7% YoY 🔸 MedTech rev: +7% YoY 🔸 Plans to split Orthopaedics into standalone business 🔸 FY rev outlook: $93.7B ($93.4B prior)"
X Link @marketsday 2025-10-14T12:26Z 19.7K followers, XXX engagements

$937b
/topic/$937b